Who depends on AstraZeneca
1 listed supplier reports AstraZeneca as a customer worth 10% or more of their revenue, led by Nektar Therapeutics at 37%.
Get an email when AstraZeneca's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Suppliers that depend on AstraZeneca
Listed companies whose annual report names AstraZeneca as a customer worth 10% or more of their revenue. If AstraZeneca cuts orders or switches supplier, these are the companies that feel it.
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Nektar TherapeuticsNKTR | 37% | ▲ from 17% | 10 years | FY 2025 · filed 13 Mar 2026 |
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Rigel PharmaceuticalsRIGL | 100% | last FY 2014 | 3 years | FY 2014 · filed 8 Mar 2016 |
| ModernaMRNA | 34% | last FY 2018 | 3 years | FY 2018 · filed 26 Feb 2021 |
| Ironwood PharmaceuticalsIRWD | 2% | last FY 2015 | 4 years | FY 2015 · filed 19 Feb 2016 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API